Follow Us

Asst.Prof.Dr Danita Kannarunimit

Sub-specialty
  • Radiation Oncology
  • Intensity modulated radiotherapy (IMRT) Image-guided radiotherapy (IGRT)
    Sub-specialty
  • Radiation Oncology
  • Intensity modulated radiotherapy (IMRT) Image-guided radiotherapy (IGRT)
    Sun
     
    Mon
     
    Tue
     
    Wed
     
    Thu
     
    Fri
     
    Sat
     
    Treatments & Services
    • Intensity modulated radiotherapy (IMRT)
    • Image-guided radiotherapy (IGRT)
    • Stereotactic radiotherapy (SRS/SRT)
    • Clinical interest in Breast, Head Neck, Lung cancer
    Education & Achievements

    Visiting Fellowship-Department of Radiation Oncology
    Memorial Sloan Kettering Cancer Center, New York, USA
    2012

    Research Fellowship
    Department of Radiation Oncology, University of California
    San Francisco, USA
    2011

    Residency
    King Chulalongkorn Memorial Hospital, Bangkok, Thailand
    2010

    Doctor of Medicine (First Class Honor)
    Faculty of Medicine, King Chulalongkorn Memorial Hospital
    Chulalongkorn University, Thailand
    2006

    Certification

    Visiting Fellowship of Memorial Sloan Kettering Cancer Center
    2013

    Research Fellowship of University California
    San Francisco
    2012

    Diploma of The Thai Board of Radiation Oncology
    2012

    Thai Medical License
    2006

    Research & Publications

    JOURNAL ARTICLE  @Technology in cancer research & treatment – Nov 6

    Analysis of Dose Distribution and Risk of Pneumonitis in Stereotactic Body Radiation Therapy for Centrally Located Lung Tumors: A Comparison of Robotic Radiosurgery, Helical Tomotherapy and Volumetric Modulated Arc Therapy.

    Kannarunimit D.;Descovich M.;Garcia A.;Chen J.;Weinberg V.;McGuinness C.;Pinnaduwage D.;Murnane J.;Murnane J.;Gottschalk AR.;Yom SS.
    DOI 10.7785/tcrt.2012.500394

    Article  @Medical Physics – –

    Comparison between target margins derived from 4DCT scans and real-time tumor motion tracking: Insights from lung tumor patients treated with robotic radiosurgery

    Descovich M.; McGuinness C.; Kannarunimit D.; Chen J.; Pinnaduwage D.; Pouliot J.; Kased N.; Gottschalk A.R.; Yom S.S.
    Volume: 42, Issue: 3, Pages: 1280-1287
    DOI 10.1118/1.4907956

    Article  @Radiation Oncology – –

    A randomized phase II/III study of adverse events between sequential (SEQ) versus simultaneous integrated boost (SIB) intensity modulated radiation therapy (IMRT) in nasopharyngeal carcinoma; preliminary result on acute adverse events

    Songthong A.P.; Kannarunimit D.; Chakkabat C.; Lertbutsayanukul C.
    Volume: 10, Issue: 1
    DOI 10.1186/s13014-015-0472-y

    Article  @JOURNAL OF RADIATION RESEARCH – JUL

    Prevalence and significance of plasma Epstein-Barr Virus DNA level in nasopharyngeal carcinoma
    Prayongrat,A;Chakkabat,C;Kannarunimit,D;Hansasuta,P;Lertbutsayanukul,C
    Volume: 58, Issue: 4, Pages: 509-516
    DOI 10.1093/jrr/rrw128

    Article  @Supportive Care in Cancer – –

    Randomized control trial of benzydamine HCl versus sodium bicarbonate for prophylaxis of concurrent chemoradiation-induced oral mucositis

    Chitapanarux I.; Tungkasamit T.; Petsuksiri J.; Kannarunimit D.; Katanyoo K.; Chakkabat C.; Setakornnukul J.; Wongsrita S.; Jirawatwarakul N.; Lertbusayanukul C.; Sripan P.; Traisathit P.
    Volume: 26, Issue: 3, Pages: 879-886
    DOI 10.1007/s00520-017-3904-4

    Article  @Strahlentherapie und Onkologie – –

    A randomized phase III study between sequential versus simultaneous integrated boost intensity-modulated radiation therapy in nasopharyngeal carcinoma [Eine randomisierte Phase-III-Studie für den Vergleich zwischen intensitätsmodulierter Strahlentherapie mit sequenziell oder mit simultan integriertem Boost bei Nasopharynxkarzinom]

    Lertbutsayanukul C.; Prayongrat A.; Kannarunimit D.; Chakkabat C.; Netsawang B.; Kitpanit S.
    Volume: 194, Issue: 5, Pages: 375-385
    DOI 10.1007/s00066-017-1251-5

    Article  @JAPANESE JOURNAL OF CLINICAL ONCOLOGY – MAY

    Optimal plasma pretreatment EBV DNA cut-off point for nasopharyngeal cancer patients treated with intensity modulated radiation therapy
    Lertbutsayanukul,C;Kannarunimit,D;Netsawang,B;Kitpanit,S;Chakkabat,C;Hansasuta,P;Prayongrat,A
    Volume: 48, Issue: 5, Pages: 467-475
    DOI 10.1093/jjco/hyy027

    Article  @Japanese journal of clinical oncology – –

    Comparison between the seventh and eighth edition of the AJCC/UICC staging system for nasopharyngeal cancer integrated with pretreatment plasma Epstein-Barr virus DNA level in a non-Chinese population: secondary analysis from a prospective randomized trial

    Kitpanit S.; Jittapiromsak N.; Sriyook A.; Prayongrat A.; Kannarunimit D.; Chakkabat C.; Lertbutsayanukul C.
    Volume: 49, Issue: 12, Pages: 1100-1113
    DOI 10.1093/jjco/hyz109